Abstract 11408: Impact of Preventable Factors of Heart Failure on One Year Rehospitalization; Insights from the Gulf CARE Study
OBJECTIVES: Heart failure (HF) re-hospitalization results in significant costs to the health care system and to patients’ quality of life and has been signaled as an important quality measure in the management of HF. The purpose of this study was to identify preventable factors associated with HF re-hospitalizations using a large multinational multicenter registry from the Middle-East.
METHODS: From February, 2012 to November, 2013, consecutive patients hospitalized with HF were enrolled from 47 hospitals in 7 Middle East countries. After hospital discharge patients were followed up at one year for re-hospitalization with HF. Patients were divided into 2 groups according to re-hospitalization with HF. Clinical feature, management and precipitating factor for hospitalization were compared among the 2 groups.
RESULTS: During the study period 5005 patients with HF were enrolled, of those 3804 (76%) were alive at one year follow-up. During this year rehospitalization with HF occurred in 1075 patients (28.3%). Noncompliance with medications and diet and myocardial ischemia were significantly more common in patients with rehospitalization compared to those with no rehospitalization (table). On multivariate analysis that included age, gender and other precipitating factor for heart failure, noncompliance with medications and diet were independent predictors of one year rehospitalization, (Medications OR 1.29 [95% CI 1.01-1.65], p= 0.04, and Diet OR 1.74 [95% CI 1.11-2.74], p= 0.02), whereas myocardial ischemia was not (OR 0.83 [95% CI 0.65-1.06], p= 0.13).
CONCLUSIONS: Patient education on the issue of compliance with medication and diet is an essential and cost-effective tool in the management of patients with HF in order to prevent rehospitalization and improve the care of individuals with HF.
Author Disclosures: A.M. Salam: None. K. Sulaiman: None. J. Al-Suwaidi: None. K. AlHabib: None. W. Almahmeed: None. A. Alsheikh-Ali: Other Research Support; Modest; Medtronic, Behringer Ingelheim. Honoraria; Modest; Boehringer Ingelheim, Bayer, Pfizer. A. Al-Motarreb: None. P. Panduranga: None. H. AlFaleh: None. A. Elasfar: None. N. Bazargani: None. M. Ridha: None. B. Bulbanat: None. M. Al-Jarallah: None. H. Amin: None. N. Asaad: None. A. Al-Qahtani: None. R. Singh: None. M. Yacoub: None.
- © 2014 by American Heart Association, Inc.